# Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

> **NCT00255437** · PHASE3 · COMPLETED · sponsor: **AMAG Pharmaceuticals, Inc.** · enrollment: 304 (—)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** ferumoxytol or oral iron

## Key facts

- **NCT ID:** NCT00255437
- **Lead sponsor:** AMAG Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 304 (—)
- **Last updated:** 2015-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255437, "Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00255437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*